Cancer Research

Cancer research involves studying the causes, progression, and treatment of cancer. This includes understanding the genetic and environmental factors which contribute in cancer’s development, its diagnostic tools and the discovering of new therapies. At CymitQuimica, we offer a wide range of compounds and reagents to support cancer research, aiding in the development of effective treatments and improving patient outcomes.

Cancer treatment

Products of "Cancer Research"

20
- 50
- 100
- 200

products per page. 1764 products on this category.

Product data	Purity	Price range	Estimated delivery
Vinorelbine Ditartrate REF: 3B-V0151CAS: 125317-39-7	>95.0%(T)(HPLC)	384.00 €	Wed 05 Mar 25
Nintedanib REF: 3B-N1313CAS: 656247-17-5	>95.0%(T)(HPLC)	78.00 €~266.00 €	Wed 05 Mar 25
Methyl (3Z)-2,3-Dihydro-3-[[[4-(methylamino)phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylate REF: 86-MM3704.11-0025CAS: 1987887-92-2	- - -	To inquire	Wed 05 Mar 25
N-Nitrosonilotinib REF: 86-MM3374.22-0025	- - -	To inquire	Wed 05 Mar 25
N-Acetylgemcitabine REF: 86-MM1257.12-0025CAS: 1026184-06-4	- - -	To inquire	Wed 05 Mar 25
Paclitaxel (1mg×5) REF: 3B-P3207CAS: 33069-62-4	- - -	89.00 €	Wed 05 Mar 25
Alfuzosin EP Impurity D (as Dihydrochloride) REF: 86-MM1004.04-0025CAS: 2732347-83-8	- - -	576.00 €	Wed 05 Mar 25
Abiraterone Acetate N-Oxide REF: 86-MM3504.18-0025CAS: 2517964-85-9	- - -	To inquire	Wed 05 Mar 25
(3β)-17-Iodoandrosta-5,16-dien-3-ol REF: 86-MM3504.10-0025CAS: 32138-69-5	- - -	To inquire	Wed 05 Mar 25
Aucubin REF: 3B-A3604CAS: 479-98-1	>98.0%(HPLC)	379.00 €	Wed 05 Mar 25
2,2'-[5-(4H-1,2,4-Triazol-4-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) (Isoanastrozole) REF: 86-MM1250.08-0025CAS: 120511-92-4	- - -	To inquire	Wed 05 Mar 25
(3β,13α)-3-(Acetyloxy)androst-5-en-17-one REF: 86-MM3504.19-0025CAS: 18462-31-2	- - -	To inquire	Wed 05 Mar 25
Methyl 2-(Bromomethyl)-3-(tert-butoxycarbonylamino)benzoate REF: 86-MM3641.14-0025CAS: 1537890-72-4	- - -	To inquire	Wed 05 Mar 25
2-(2,6-Dioxo-3-piperidinyl)-4-(hydroxyamino)-1H-isoindole-1,3(2H)-dione REF: 86-MM3919.01-0025CAS: 497147-11-2	- - -	839.00 €	Wed 05 Mar 25
4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile REF: 86-MM1143.03-0025CAS: 112809-25-3	- - -	695.00 €	Wed 05 Mar 25
Palbociclib REF: 86-MM3729.00-0250CAS: 571190-30-2	- - -	2,214.00 €	Wed 05 Mar 25
Bosutinib REF: 3B-B4824CAS: 380843-75-4	>95.0%(T)(HPLC)	199.00 €	Wed 05 Mar 25
LW 6 REF: 3B-L0334CAS: 934593-90-5	>97.0%(HPLC)	188.00 €~539.00 €	Wed 05 Mar 25
AG-1296 REF: 3B-D4601CAS: 146535-11-7	>98.0%(GC)	78.00 €~248.00 €	Wed 05 Mar 25
(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide Hydrochloride (Bortezomib Intermediate II) REF: 86-MM3368.04-0025CAS: 205393-21-1	- - -	901.00 €	Wed 05 Mar 25

25mg		188.00 €
100mg		539.00 €

5mg		78.00 €
25mg		248.00 €

Cancer Research

Subcategories of "Cancer Research"

Cancer treatment

Products of "Cancer Research"

Vinorelbine Ditartrate

Ref: 3B-V0151

Nintedanib

Ref: 3B-N1313

Methyl (3Z)-2,3-Dihydro-3-[[[4-(methylamino)phenyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylate

Ref: 86-MM3704.11-0025

N-Nitrosonilotinib

Ref: 86-MM3374.22-0025

N-Acetylgemcitabine

Ref: 86-MM1257.12-0025

Paclitaxel (1mg×5)

Ref: 3B-P3207

Alfuzosin EP Impurity D (as Dihydrochloride)

Ref: 86-MM1004.04-0025

Abiraterone Acetate N-Oxide

Ref: 86-MM3504.18-0025

(3β)-17-Iodoandrosta-5,16-dien-3-ol

Ref: 86-MM3504.10-0025

Aucubin

Ref: 3B-A3604

2,2'-[5-(4H-1,2,4-Triazol-4-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile) (Isoanastrozole)

Ref: 86-MM1250.08-0025

(3β,13α)-3-(Acetyloxy)androst-5-en-17-one

Ref: 86-MM3504.19-0025

Methyl 2-(Bromomethyl)-3-(tert-butoxycarbonylamino)benzoate

Ref: 86-MM3641.14-0025

2-(2,6-Dioxo-3-piperidinyl)-4-(hydroxyamino)-1H-isoindole-1,3(2H)-dione

Ref: 86-MM3919.01-0025

4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile

Ref: 86-MM1143.03-0025

Palbociclib

Ref: 86-MM3729.00-0250

Bosutinib

Ref: 3B-B4824

LW 6

Ref: 3B-L0334

AG-1296

Ref: 3B-D4601

(alphaS)-α-Amino-N-[(1R)-1-[(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]benzenepropanamide Hydrochloride (Bortezomib Intermediate II)

Ref: 86-MM3368.04-0025